BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person ImmuneBD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study

FRANKLIN LAKES, N.J., Dec. 18, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania, to advance research in deep human immune profiling and support the development of immune-mediated therapies.

The collaboration includes developing and validating a high-parameter flow cytometry panel that can capture key functional pathways in whole blood, including phosphorylation markers, which provide powerful insight into how single cells respond to drugs or disease states. The panel will support a planned 1,000-patient immune profiling study, in partnership with the Penn Colton Center for Autoimmunity, expected to start this summer. The project will leverage the BD FACSDiscover™ A8 Cell Analyzer, BD Rhapsody™ System, BD reagents, software and informatics, with BD teams managing reagents, instrumentation, and spectral data algorithms, and I3H teams serving as scientific and clinical leads. The team intends to publish a peer-reviewed manuscript describing the results of the study.

“This project demonstrates the power of collaboration between academia and industry,” said Dr. E. John Wherry, PhD, the Richard and Barbara Schiffrin President’s Distinguished Professor, director of the Institute for Immunology and Immune Health at the University of Pennsylvania, and the director of the Colton Consortium for Autoimmunity. “We are bringing together cross-functional experts to transform human immune profiling for maximum impact, enabling deeper insights from our immune cells that could accelerate development of precise medical treatments.”

The collaboration reflects a shared vision of unlocking the power of the human immune system to advance science and health. It is made possible by the BD FACSDiscover™ A8 Cell Analyzer, which is the first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, and the new BD Horizon™ Chroma solution for dried high-parameter panels. The project supports the commitment of both organizations to contribute to the research community through collaboration and knowledge sharing.

“High-parameter single-cell studies of this kind, once considered infeasible, are increasingly becoming central to better understanding the human immune system,” said Steve Conly, worldwide president of BD Biosciences. “Our ecosystem of industry-leading BD flow cytometers, single-cell systems, reagents, software and informatics, provide a critical missing puzzle piece that can support the important work of organizations like I3H to translate and deliver immunological insights into quantitative, actionable information for discovery and clinical care teams around the world.”

More information is available at bdbiosciences.com.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:

Media:

Investors:

Fallon McLoughlin

Adam Reiffe

Director, Public Relations

VP, Investor Relations

201.258.0361

201.847.6927

fallon.mcloughlin@bd.com

adam.reiffe@bd.com

Media for Penn Medicine:

Eric Horvath

Associate News Director

Penn Medicine

215-821-4289

Eric.horvath@pennmedicine.upenn.edu

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-and-penn-institute-for-immunology-and-immune-health-collaborate-to-advance-immunotherapy-through-flow-cytometry-302645260.html

SOURCE BD (Becton, Dickinson and Company)

Market Opportunity
FLOW Logo
FLOW Price(FLOW)
$0.175
$0.175$0.175
+1.27%
USD
FLOW (FLOW) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Satoshi-Era Mt. Gox’s 1,000 Bitcoin Wallet Suddenly Reactivated

Satoshi-Era Mt. Gox’s 1,000 Bitcoin Wallet Suddenly Reactivated

The post Satoshi-Era Mt. Gox’s 1,000 Bitcoin Wallet Suddenly Reactivated appeared on BitcoinEthereumNews.com. X account @SaniExp, which belongs to the founder of the Timechain Index explorer, has published data showing that a dormant BTC wallet was activated after hibernating for six years. However, it was set up 13 years ago, according to the tweet — the time when Satoshi Nakamoto’s shadow was still casting itself around, so to speak. The X post states that the tweet belongs to infamous early Bitcoin exchange Mt. Gox, which suffered from a major hack in the early 2010s, and last year it began paying out compensation to clients who lost their crypto in that hack. The deadline was eventually extended to October 2025. Mt. Gox’s wallet with 1,000 BTC reactivated The above-mentioned data source shared a screenshot from the Timechain Index explorer, showing multiple transactions marked as confirmed and moving a total of 1,000 Bitcoins. This amount of crypto is valued at $116,195,100 at the time of the initiated transaction. Last year, Mt. Gox began to move the remains of its gargantuan funds to pay out compensations to its creditors. Earlier this year, it also made several massive transactions to partner exchanges to distribute funds to Mt. Gox investors. All of the compensations were promised to be paid out by Oct. 31, 2025. The aforementioned transaction is likely preparation for another payout. The exchange was hacked for several years due to multiple unnoticed security breaches, and in 2014, when the site went offline, 744,408 Bitcoins were reported stolen. Source: https://u.today/satoshi-era-mtgoxs-1000-bitcoin-wallet-suddenly-reactivated
Share
BitcoinEthereumNews2025/09/18 10:18
Zycus Launches Industry-First AI Adoption Index to Measure Real-World AI Maturity in Procurement

Zycus Launches Industry-First AI Adoption Index to Measure Real-World AI Maturity in Procurement

Princeton, NJ | Dec 26th, 2025 — Zycus, a global leader in AI-powered Source-to-Pay (S2P) solutions, today announced the launch of the AI Adoption Index for Procurement
Share
Techbullion2025/12/26 17:57
Soccer Replica Jerseys – Kits, Customization, and Best Practices for Caring for Them

Soccer Replica Jerseys – Kits, Customization, and Best Practices for Caring for Them

Today’s soccer jersey is more than just athletic clothing; it is a representation of loyalty, a statement of fashion, and an example of technical development. The
Share
Techbullion2025/12/26 18:04